PacificHealth Laboratories, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PHLI research report →
Price Chart
About the company
PacificHealth Laboratories, Inc. (PHLI) specializes in developing and marketing nutritional products designed to boost overall health and enhance athletic performance for consumers both within the United States and internationally. The company's offerings predominantly target key aspects of athletic performance, such as optimal sports performance, proper hydration, sustained energy (fueling), and efficient muscle recovery.
- IPO
- 1997
- Employees
- 8
- HQ
- Matawan, NJ, US
Get TickerSpark's AI analysis on PHLI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $438.31K
- P/E
- -0.00
- PEG
- 0.00
- P/S
- 0.06
- P/B
- 0.00
- EV/EBITDA
- 0.58
- Div Yield
- 0.00%
- Gross Margin
- 43.20%
- Op Margin
- -6.86%
- Net Margin
- -7.03%
- ROE
- -54.44%
- ROIC
- -36.82%
Latest fiscal year · YoY change
- Revenue
- $6.91M-4.0%
- Gross Profit
- $2.99M-5.6%
- Op Income
- $-474,218
- Net Income
- $-486,311+36.1%
- EPS
- $-0.02+47.2%
- OCF Growth
- -135.2%
- FCF Growth
- -103.4%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -329.07
- RSI (14)
- 6
- Avg Volume
- 244
No earnings-call transcripts are available for PHLI yet.
- Free Float
- 0.4%
- Shares Outstanding
- 4.38B
- Float Shares
- 19.70M
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 30, 10 | Mizel Adam | other | 73,171 |
| Mar 31, 10 | Mizel Adam | other | 70,588 |
| Dec 31, 09 | Mizel Adam | other | 42,857 |
| Sep 30, 09 | Mizel Adam | other | 23,077 |
| Sep 8, 09 | Mizel Adam | buy | 5,000 |
| Sep 4, 09 | Mizel Adam | buy | 5,000 |
| Sep 8, 09 | Mizel Adam | buy | 5,000 |
| Sep 4, 09 | Mizel Adam | buy | 5,000 |
| Jun 30, 09 | Mizel Adam | other | 20,000 |
| Apr 3, 09 | Mizel Adam | other | 40,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our PHLI coverage
Recent articles, reports, and earnings notes.
No research on PHLI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PHLI report →